Tenderwize
Zurück zur Suche

Open house pharmaceutical discount agreements for active substance Biperiden, ATC N04AA02

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 217 days left·Open·Supplies
Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Biperiden, ATC N04AA02

45/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Warum diese Bewertung?

Chance

45 / 100

Komplexität

30 / 100

Risikofaktoren

The buyer reserves the right to replace open-house agreements with exclusive discount contracts, which would automatica...

No estimated volume or value; discount rates are not specified but must be agreed upon. The actual profitability depend...

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Moderate opportunity

Wichtige Fakten

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Supply of authorized and marketable pharmaceutical products containing Biperiden (ATC N04AA02).
  • Agreement to offer discount on the drug's price as per SGB V §§130a(8)/130c(1).
Vollständige Zusammenfassung anzeigen

This is an open-house model for non-exclusive pharmaceutical discount agreements on the active substance Biperiden (ATC N04AA02) with AOK Rheinland-Pfalz/Saarland. The contract is not a public procurement under EU directives but published voluntarily for transparency. The procedure allows any interested pharmaceutical company to enter into a standard agreement at any time during a 24-month window (June 2025 – May 2027), with uniform conditions. No estimated value is provided. The buyer reserves the right to replace these agreements with exclusive ones through separate tenders, which would automatically terminate open-house contracts.

Risiken

The buyer reserves the right to replace open-house agreements with exclusive discount contracts, which would automatica...

No estimated volume or value; discount rates are not specified but must be agreed upon. The actual profitability depend...

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • Products must be authorized and marketable in Germany (verified via Lauer-Taxe or AMIce database).

Administrative

  • Submission of signed contract documents and supporting evidence of drug authorization/marketability.
  • No electronic submission allowed; documents must be submitted in original.

Auftraggeber

Lose (1)

LOT-0001

Open house pharmaceutical discount agreements for active substance Biperiden, ATC N04AA02

Non-exclusive discount agreements for Biperiden products. All interested pharmaceutical companies can join under uniform terms. Maximum contract duration 24 months. First possible start date: 01.06.2025. Contracts can be terminated by the buyer early if exclusive agreements are concluded.

SuppliesEU fundedElectronic submission

Ort

Eisenberg, Germany

Dauer

May 2025 - May 2027

Kategorie

Pharmaceutical products

Vergabedetails

Veröffentlichungsdatum
10 Apr 2025
Sprachen
German

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
235451-2025

Dokumente (1)

Ähnliche Ausschreibungen